Thelansis’s “Peeling Skin Syndrome (PSS) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication.
Peeling skin syndrome (PSS) is a rare group of inherited skin disorders characterized by recurrent, spontaneous shedding of the superficial epidermal layers due to genetic defects affecting skin adhesion and barrier function. Depending on the subtype, patients may develop generalized or acral peeling, erythema, pruritus, blistering, and increased sensitivity to heat, friction, or moisture. In inflammatory forms, atopic manifestations and recurrent skin infections may further affect quality of life. There is currently no approved disease-specific therapy, and management is primarily supportive, with emollients, trigger avoidance, skin care, and treatment of complications. The therapeutic landscape remains an area of high unmet need, with research focused on disease mechanisms and potential molecularly targeted approaches to restore epidermal integrity. Advances in genetic diagnosis and precision medicine may support future development of subtype-specific therapies.
G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)
*Survey is customized based on client requirements
1. Key Findings and Analyst Commentary
2. Competitive Landscape
3. Product Attribute Analysis
4. Primary Market Research
5. Unmet Need and TPP Analysis
6. Regulatory and Reimbursement Environments (by country and payer insights)
7. Appendix (e.g., bibliography, methodology)
No snapshots available.
That depends on the file type you choose: the Excel epidemiology model, the Excel market forecast model with dashboard, and the full analyst report in PowerPoint with a PDF version.
Within 48 to 72 hours of purchase.
Yes. Choose EU5, G7 or G8, or pick individual markets in the panel.
Yes. Request a free sample to preview the scope and sample pages.
Yes. The forecast model is customizable, and our analysts can tailor the scope to your questions.
Yes. Inquire for bundle discounted pricing and we will send you exclusive pricing for the reports you need.
Choose the file type you want to purchase or request.
No file type found.
Select markets to include.
No markets match your search.
Not sure which report fits your question? Our team will point you to the right one.
Tell us what you are looking for and we will tailor the research to your indication, markets and questions.
Prefer to talk it through? Email clientsupport@thelansis.com
You asked for for covering . We will reply to .
Fill in your details and our expert consultants will get in touch with you.
Get a sneak peek at the latest Peeling Skin Syndrome (PSS) – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026 report
Our team will get in touch with you shortly about the Peeling Skin Syndrome (PSS) – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026 report.